Veterinary Cardiology Market Report 2026

The veterinary cardiology market size has grown strongly in recent years. It will grow from $3.1 billion in 2025 to $3.38 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increased prevalence of congenital heart defects in pets, rising awareness about pet healthcare, growing number of veterinary hospitals and clinics, advancements in diagnostic imaging technologies, adoption of conventional pharmaceuticals for cardiac diseases.

The veterinary cardiology market size is expected to see strong growth in the next few years. It will grow to $4.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to rising adoption of telemedicine in veterinary cardiology, growth in pet insurance coverage, development of AI-enabled diagnostic tools, increased focus on preventive and personalized cardiac care, expansion of companion animal population in urban regions. Major trends in the forecast period include telecardiology & remote cardiac monitoring, minimally invasive cardiac procedures, personalized treatment plans for companion animals, advanced cardiac imaging techniques, nutraceuticals & preventive cardiac care.

The rising incidence of heart diseases in pets and livestock is expected to drive the growth of the veterinary cardiology market going forward. Heart diseases in pets and livestock include medical conditions affecting the structure and function of the heart, leading to impaired blood circulation, reduced cardiac efficiency, and potential health complications. The increase in heart disease cases is driven by factors such as longer lifespans, obesity, poor diet, genetic predispositions, and insufficient regular veterinary care. Environmental stressors and changes in living conditions further contribute to the prevalence of cardiovascular conditions in these animals. Veterinary cardiology supports the diagnosis, treatment, and management of heart diseases through specialized care, advanced imaging, and innovative procedures, including minimally invasive surgeries, to improve cardiac health and quality of life. For example, in March 2024, according to the American Veterinary Medical Association, a US-based not-for-profit organization, myxomatous mitral valve degeneration (MMVD) is the most common heart disease in dogs in North America, accounting for 75% of all canine cardiac conditions. Among small dogs aged 13 years, 85% show signs of a mitral valve lesion, although its clinical significance may vary. In cases of MMVD, cardiac-related deaths in dogs are estimated between 40% and 70%. Therefore, the rising incidence of heart diseases in pets and livestock is driving the growth of the veterinary cardiology market.

Leading players in the veterinary cardiology market are developing technological innovations, such as transcatheter edge-to-edge mitral valve repair (TEER), to enhance the treatment of heart diseases, improve surgical outcomes, and provide minimally invasive alternatives for better recovery and quality of life. TEER is a less invasive procedure designed to correct mitral valve leakage by using a clamp to improve valve function and reduce cardiac strain. For example, in February 2023, Willows Veterinary Centre, a UK-based veterinary referral center, launched an advanced heart treatment for dogs with myxomatous mitral valve disease (MMVD), the most common heart condition in dogs. This procedure is considered a viable alternative to surgical repair in human patients, with early clinical results in dogs showing promising outcomes. The procedure is performed under general anesthesia through a minor chest incision. A needle is inserted at the heart’s apex, with precise guidance from continuous X-rays and transesophageal ultrasound, allowing accurate placement of a V-clamp across the mitral valve to reduce leakage.

In October 2023, EQT AB, a Sweden-based investment organization, acquired VetPartners for $940 million. This acquisition supports EQT's strategy to expand its investment portfolio within the animal health sector, aiming to elevate veterinary service standards and address increasing demand for animal healthcare. VetPartners is a UK-based veterinary group providing comprehensive cardiology care and services for animals.

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Santé Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet.

North America was the largest region in the veterinary cardiology market in 2025. The regions covered in the veterinary cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the veterinary cardiology market by increasing the cost of importing advanced diagnostic equipment and specialized pharmaceuticals, impacting the availability of high-end imaging devices and cardiac drugs. The segments most affected include diagnostics and pharmaceuticals, particularly in regions like Asia-Pacific and North America that rely on imported technologies. While costs have risen, tariffs have also encouraged local manufacturing and innovation in cost-effective cardiac care solutions, providing new opportunities for regional players.

The veterinary cardiology market research report is one of a series of new reports that provides veterinary cardiology market statistics, including veterinary cardiology industry global market size, regional shares, competitors with a veterinary cardiology market share, detailed veterinary cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary cardiology industry. This veterinary cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Veterinary cardiology is a specialized field of veterinary medicine dedicated to diagnosing and managing heart diseases in animals. This branch ranges from routine examinations to advanced treatments, aiming to enhance pets' quality of life by providing targeted diagnosis and treatment for heart conditions, which leads to better health outcomes and longer lifespans.

The primary product types in veterinary cardiology are pharmaceuticals and diagnostics. Pharmaceuticals refer to the medications used to treat heart conditions in animals, such as managing heart failure, arrhythmias, and other cardiovascular issues. Indications for these medications include congestive heart failure, myocardial disease, arrhythmias, and other heart conditions affecting companion animals and production animals. The end users of these products include veterinary hospitals, clinics, and other related facilities.

The veterinary cardiology market consists of revenues earned by entities by providing services such as educational services, emergency care, telemedicine services, follow-up care, and consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. veterinary cardiology market also includes sales of monitoring devices, treatment products, supportive products, and surgical products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.